Home/Filings/4/0000899243-21-019193
4//SEC Filing

COX MARK K 4

Accession 0000899243-21-019193

CIK 0000915389other

Filed

May 11, 8:00 PM ET

Accepted

May 12, 12:19 PM ET

Size

39.8 KB

Accession

0000899243-21-019193

Insider Transaction Report

Form 4
Period: 2021-05-10
COX MARK K
Senior Vice President
Transactions
  • Sale

    Common Stock

    2021-05-10$125.70/sh3,141$394,8243,024 total
  • Sale

    Common Stock

    2021-05-10$125.16/sh18,531$2,319,3403,024 total
  • Sale

    Common Stock

    2021-05-10$125.17/sh6,450$807,3473,024 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2021-05-1018,5310 total
    Exercise: $104.21From: 2021-02-26Exp: 2028-02-25Common Stock (18,531 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2021-05-1013,9826,992 total
    Exercise: $82.69From: 2021-02-28Exp: 2029-02-27Common Stock (13,982 underlying)
  • Exercise/Conversion

    Common Stock

    2021-05-10$87.43/sh+3,141$274,6186,165 total
  • Sale

    Common Stock

    2021-05-10$125.60/sh6,949$872,7943,024 total
  • Exercise/Conversion

    Common Stock

    2021-05-10$80.25/sh+15,074$1,209,68918,098 total
  • Sale

    Common Stock

    2021-05-10$125.29/sh15,074$1,888,6213,024 total
  • Exercise/Conversion

    Common Stock

    2021-05-10$82.69/sh+13,982$1,156,17217,006 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2021-05-106,9490 total
    Exercise: $65.16From: 2019-02-26Exp: 2026-02-25Common Stock (6,949 underlying)
  • Exercise/Conversion

    Common Stock

    2021-05-10$65.16/sh+6,949$452,7979,973 total
  • Exercise/Conversion

    Common Stock

    2021-05-10$61.51/sh+6,450$396,7409,474 total
  • Exercise/Conversion

    Common Stock

    2021-05-10$104.21/sh+18,531$1,931,11621,555 total
  • Sale

    Common Stock

    2021-05-10$124.91/sh13,982$1,746,4923,024 total
  • Gift

    Common Stock

    2021-05-101,3601,664 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2021-05-103,1410 total
    Exercise: $87.43From: 2017-02-28Exp: 2024-02-27Common Stock (3,141 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2021-05-1015,0740 total
    Exercise: $80.25From: 2020-02-28Exp: 2027-02-27Common Stock (15,074 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2021-05-106,45012,900 total
    Exercise: $61.51From: 2021-02-28Exp: 2030-02-27Common Stock (6,450 underlying)
Footnotes (8)
  • [F1]Average weighted sale price for shares disposed of in the reported transaction. The shares were sold in multiple broker's transactions at various prices per share ranging from $125.67 to $125.71. The reporting person undertakes to provide to the issuer, any stockholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).
  • [F2]Average weighted sale price for shares disposed of in the reported transaction. The shares were sold in multiple broker's transactions at various prices per share ranging from $125.52 to $125.67. The reporting person undertakes to provide to the issuer, any stockholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).
  • [F3]Average weighted sale price for shares disposed of in the reported transaction. The shares were sold in multiple broker's transactions at various prices per share ranging from $125.09 to $125.48. The reporting person undertakes to provide to the issuer, any stockholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3).
  • [F4]Average weighted sale price for shares disposed of in the reported transaction. The shares were sold in multiple broker's transactions at various prices per share ranging from $125.03 to $125.38. The reporting person undertakes to provide to the issuer, any stockholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4).
  • [F5]Average weighted sale price for shares disposed of in the reported transaction. The shares were sold in multiple broker's transactions at various prices per share ranging from $124.80 to $125.10. The reporting person undertakes to provide to the issuer, any stockholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5).
  • [F6]Average weighted sale price for shares disposed of in the reported transaction. The shares were sold in multiple broker's transactions at various prices per share ranging from $125.12 to $125.17. The reporting person undertakes to provide to the issuer, any stockholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (6).
  • [F7]One-third of the option became exercisable on February 28, 2020 and February 28, 2021, respectively and one-third of the option becomes exercisable on February 28, 2022.
  • [F8]One-third of the option became exercisable on February 28, 2021 and one-third of the option becomes exercisable on February 28, 2022 and February 28, 2023, respectively.

Issuer

EASTMAN CHEMICAL CO

CIK 0000915389

Entity typeother

Related Parties

1
  • filerCIK 0001595866

Filing Metadata

Form type
4
Filed
May 11, 8:00 PM ET
Accepted
May 12, 12:19 PM ET
Size
39.8 KB